Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

August 3, 2007

Growth factor use

Analysis of: Amgen Responds to Final CMS National Coverage Determination on Use of Erythropoiesis-Stimulating Agents in Oncology | www.pipelinereview.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Taral Patel, MD, OncologistTaral Patel, MD
Oncologist, Mid Ohio Oncology Hematology Inc.
Implications: Decrease use by 20-25% use of ESA. This may lead discounting and higher rebate from both amgen and orto-biotech to sustain market share. Since most of amgen contract with aranesp and neulasta use. It may effect use of neulasta. Next 6 month CMS may restrict use of Neulasta and neupogen for neutropenia associated with chemotherapy.

Analysis: Decrease use by 20-25% use of ESA. This may lead discounting and higher rebate from both amgen and orto-biotech to sustain market share. Since most of amgen contract with aranesp and neulasta use. It may effect use of neulasta. Next 6 month CMS may restrict use of Neulasta and neupogen for neutropenia associated with chemotherapy.

Other Analyses of the Same Source Article:
THe CMS uses ESAs to start restricting cancer care
August 9, 2007, Author: Donald Fleming, MD, Division Head of Hematology and Oncology, Davis Health System, Inc.
ESA use guidelines are fair and may lead to lower prices
August 6, 2007, Author: GLG Expert Contributor
ESA
August 6, 2007, Author: Taral Patel, MD, Oncologist, Mid Ohio Oncology Hematology Inc.
The Good News Is....
August 3, 2007, Author: GLG Expert Contributor
Allowing non-physicians to practice medicine
August 3, 2007, Author: GLG Expert Contributor

Report a Concern

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-04T17:45:17.897